We intend to focus our search for a target business in the healthcare or healthcare-related industries in the United States and Europe. In particular, we intend to prioritize companies in the life sciences and pharmaceutical services sectors, where our management team has extensive experience.

We are a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations. (AAV stands for adeno-associated virus.) Our most advanced product candidates include TSHA-101, which is being developed to treat genetic disorders that include Tay-Sachs disease, […]

We have not selected any business combination target, and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. Our sponsor is Bluescape Sponsor LLC, an affiliate of Bluescape Energy Partners, a private investment firm based in Dallas, Texas, with a value-oriented focus. We […]

  Laird Superfood is an emerging consumer products platform focused on manufacturing and marketing highly differentiated plant-based and functional foods. The Laird Superfood brand is increasingly recognized and trusted by a growing number of consumers. The core pillars of the Laird Superfood platform are currently Superfood Creamer coffee creamers, Hydrate hydration products and beverage-enhancing supplements, […]

We are a blank check company newly incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.  While we may pursue an […]

We provide integrated downstream LNG solutions to underserved markets by delivering low cost, environmentally sound energy alternatives to consumers around the world. Our business includes (i) our network of existing and development stage marine LNG import terminals, (ii) our ownership of interests in existing and development stage large-scale power plants backed by high quality offtakers, and (iii) the […]

Reid Hoffman, Mark Pincus, and Michael Thompson have established Reinvent Technology Partners, a newly formed blank check company, to partner with a technology business to innovate and achieve entrepreneurship at scale by leveraging their operating expertise as founders of iconic technology companies, their experience building companies as advisors and board members, and the capital raised […]

We are a mental health care company pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support, to help people with treatment-resistant depression. We have developed a proprietary high-purity polymorphic crystalline formulation of psilocybin, COMP360. In 2019, we completed a Phase I clinical trial administering […]

  While we may pursue an acquisition opportunity in any business, industry, sector or geographical location, we intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business focusing on technology growth companies in the northern part of Europe, including […]

  Our mission is to help Americans get the healthcare they need at a price they can afford. To achieve this, we are building the leading, consumer-focused digital healthcare platform in the United States. GoodRx was founded to solve the challenges that consumers face in understanding, accessing, and affording healthcare. We started with a price […]